QI program can up outcomes for neonatal abstinence syndrome

QI program can up outcomes for neonatal abstinence syndrome

(HealthDay)—Significant improvements in neonatal abstinence syndrome (NAS) outcomes can result from a comprehensive quality improvement (QI) program, according to a study published in the August issue of the Journal of Perinatology.

Elisha M. Wachman, M.D., from Boston Medical Center, and colleagues compared pre- and post-intervention NAS outcomes after a QI initiative in opioid-exposed infants ≥36 weeks. The initiative included a non-pharmacologic care bundle; function-based assessments comprising symptom prioritization and the Eat, Sleep, Console tool; and a switch to methadone for pharmacologic .

The researchers observed significant decreases in pharmacologic treatment (from 87.1 to 40 percent), adjunctive agent use (from 33.6 to 2.4 percent), hospitalization length of stay (from 17.4 to 11.3 days), and opioid treatment days (from 16.2 to 12.7). Per infant, total hospital charges decreased from $31,825 to $20,668. There was a significant increase in parental presence (from 55.6 to 75.8 percent). There were no adverse events.

"A comprehensive QI program focused on non-pharmacologic care, function-based assessments, and methadone resulted in significant sustained improvements in NAS outcomes," the authors write. "These findings have important implications for establishing potentially better practices for opioid-exposed newborns."

More information: Abstract/Full Text (subscription or payment may be required)

Journal information: Journal of Perinatology

Copyright © 2018 HealthDay. All rights reserved.

Citation: QI program can up outcomes for neonatal abstinence syndrome (2018, August 17) retrieved 23 May 2024 from https://medicalxpress.com/news/2018-08-qi-outcomes-neonatal-abstinence-syndrome.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Non-pharmacologic approaches improve outcomes for infants with neonatal abstinence syndrome


Feedback to editors